… activities hindered their development. To overcome these … level and in an inflammatory bowel
disease model. This work not … -engineered strategy to develop self-cascading nanozymes …

… Short-chain fatty acids (SCFAs) are microbial products that can be applied as potential
immunonutrition therapies for inflammatory bowel diseases. SCFAs can prevent the development …

… mechanisms in inflammation-related diseases. Inflammatory bowel diseases (IBDs), which
… Due to the multifactorial etiology of these diseases, the development of innovative treatment …

… Gene-wide association studies and functional characterizations suggest a potential role for
impaired bile acid signaling in development inflammatory bowel diseases (IBD). In this review…

… pathways involved in innate and adaptive immunity are thought to be pivotal in the development
and persistence of inflammation in IBD 37 . Impaired barrier function of the epithelium …

… A therapeutic strategy that targets multiple proinflammatory factors in inflammatory bowel
disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a drug-…

… compounds are the first choice when we are developing drugs to treat colitis. In addition,
most of the experimental studies have been performed on mice model and the identical …

… in inflammatory bowel disease (IBD) patients has been attributed to long-standing chronic
inflammation… the important role of inflammation in the development of IBD-CRC, the use of anti-…

… duration, history of resection, and age that seem to increase risk of development of NAFLD.
Inflammatory bowel disease treatment history and exposure to steroids and methotrexate are …

… Inflammation has a strong role in the development of … Several systemic inflammatory conditions
have been linked to an … Inflammatory Bowel Disease (IBD). IBD is comprised of Ulcerative …